Cargando…
Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature
Only a few cases of pityriasis rosea (PR)/pityriasis rosea-like eruption (PRLE) after anti-SARS-CoV-2 vaccination have been reported. In the period May 2021- February 2022 we observed five cases of clinically typical PR that appeared 2 to 3 weeks after anti-SARS-CoV-2 vaccination with BNT162b2 (3 pa...
Autores principales: | Veraldi, Stefano, Boneschi, Vinicio, Cusini, Marco, Maronese, Carlo Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099291/ https://www.ncbi.nlm.nih.gov/pubmed/37063394 http://dx.doi.org/10.4081/dr.2022.9503 |
Ejemplares similares
-
Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them?
por: Drago, Francesco, et al.
Publicado: (2018) -
Pityriasis rosea and pityriasis rosea-like eruptions after COVID-19 vaccines
por: Drago, Francesco, et al.
Publicado: (2022) -
Terbinafine induced pityriasis rosea-like eruption
por: George, Anisha, et al.
Publicado: (2015) -
Pityriasis rosea, pityriasis rosea–like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination
por: Drago, Francesco, et al.
Publicado: (2022) -
Manifestation of pityriasis rosea and pityriasis rosea‐like eruptions after Covid‐19 vaccine: A systematic review
por: Khan, Iman, et al.
Publicado: (2023)